Novel cancer therapy extends lives of terminally ill dogs, shows potential for use in human patients

Dr. Sarah Ho prepares the engineered Mesenchymal Stem Cells. Credit: NUS Yong Loo Lin School of Medicine Researchers from the Department of Biochemistry and NUS Centre for Cancer Research (N2CR), at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have been pioneering a treatment using stem cell precision engineering technology, to deliver drugs directly to tumor sites in dogs and cats with late-stage cancer and no treatment options available. To date, the treatment has been administered to nearly 100 dogs and cats with conditions such Read More

Related posts:

  1. New combination therapy shows promise for bladder cancer patients unresponsive to standard treatment
  2. Radioligand therapy extends progression-free survival with manageable safety profile in advanced prostate cancer
  3. Reinvigorating exhausted immune cells reveals potential therapy target for cancer
  4. Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patients
  5. Stem cell-derived therapy shows promise against treatment-resistant liver cancer
  6. Acupuncture reduces hot flashes in breast cancer therapy patients, study finds
  7. Novel radiotracer rapidly detects gastrointestinal cancer biomarker, identifies patients for targeted therapy
  8. Pfizer drug extends life for people with rare form of lung cancer

Leave a Reply

Your email address will not be published. Required fields are marked *